Allelic variants of natriuretic peptide receptor genes are associated with family history of hypertension and cardiovascular phenotype
- 1 August 2003
- journal article
- research article
- Published by Wolters Kluwer Health in Journal Of Hypertension
- Vol. 21 (8) , 1491-1496
Abstract
Objective Abnormalities in the natriuretic peptide system could play a key role in the genesis of hypertension. We evaluated the associations between a family history of hypertension, cardiovascular phenotype and allelic variants of Npr1 and Npr3, two candidate genes that codify for natriuretic peptide receptors. Methods We genotyped 45 young normotensive subjects (19 males, 26.8 ± 3.7 years) with accurately assessed family history of hypertension (FH+) and 52 (26 males, 26.1 ± 3.1 years) without (FH−) for the known variants of Npr1 and Npr3 genes, and for a novel length difference (3C/4C) polymorphism at position 15129 in the 3′-untranslated region of the Npr1 gene. Blood pressure, echocardiography and plasma brain natriuretic peptide were assessed. Results Both the novel Npr1 3C allele (59 versus 33%, P< 0.001) and the 3C/3C genotype (31 versus 8%; P< 0.001) were significantly more frequent in FH+ than in FH−. The inverse distribution of the 4C/4C genotype suggested that a casual association was very unlikely. Moreover, the 3C/3C homozygous had significantly higher systolic blood pressure (121.1 ± 6.3 versus 115.6 ± 7.8 mmHg in 4C/4C; P< 0.05) and a longer left ventricular isovolumic relaxation time (67 ± 10 versus 61 ± 9 ms; P< 0.05). The Npr3 C(−55) allele variant was also more frequent in FH+ (88 versus 76%, P< 0.05), but was not associated with the cardiovascular phenotype. Conclusions The novel Npr1 gene 3C variant and the Npr3 gene C(−55) allele are associated with hypertensive family history. Moreover, the functional Npr1 3C variant, when homozygous, is also associated with higher systolic blood pressure and prolonged ventricular relaxation.Keywords
This publication has 21 references indexed in Scilit:
- Cardiovascular phenotype of young adults and angiotensinogen allelesJournal Of Hypertension, 2001
- Pressure-independent enhancement of cardiac hypertrophy in natriuretic peptide receptor A–deficient miceJournal of Clinical Investigation, 2001
- Influence of gender and family history of hypertension on autonomic control of heart rate, diastolic function and brain natriuretic peptideJournal Of Hypertension, 2001
- Functional Deletion Mutation of the 5′-Flanking Region of Type A Human Natriuretic Peptide Receptor Gene and Its Association With Essential Hypertension and Left Ventricular Hypertrophy in the JapaneseCirculation Research, 2000
- Natriuretic PeptidesNew England Journal of Medicine, 1998
- Hypertension, cardiac hypertrophy, and sudden death in mice lacking natriuretic peptide receptor AProceedings of the National Academy of Sciences, 1997
- Role of atrial natriuretic factor in volume controlKidney International, 1996
- Salt-resistant hypertension in mice lacking the guanylyl cyclase-A receptor for atrial natriuretic peptideNature, 1995
- Physiology of natriuretic peptidesJournal of Internal Medicine, 1994
- The Bergen Blood Pressure Study: Inappropriately Low Levels of Circulating Atrial Natriuretic Peptide in Offspring of Hypertensive FamiliesBlood Pressure, 1994